Roche Launches New SP116 Antibody to Aid in Prostate Cancer Diagnosis

Roche Launches New SP116 Antibody to Aid in Prostate Cancer Diagnosis
Roche says clinicians can now access its anti-p504 (SP116) antibody to help diagnose men with prostate cancer, representing a new way to detect the disease early using a simple laboratory assay. SP116, a monoclonal primary antibody, recognizes specific regions of a protein called α-methylacyl-CoA racemase (AMACR) — a useful biomarker in prostate adenocarcinoma due to its increased protein expression compared to healthy prostate tissues. The novel antibody can efficiently diagnose prostate cancer when
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *